Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

OLIG2 anticorps (AA 1-141)

L’anticorps Souris Monoclonal anti-OLIG2 a été validé pour IHC (f). Il convient pour détecter OLIG2 dans des échantillons de Humain.
N° du produit ABIN6939031

Aperçu rapide pour OLIG2 anticorps (AA 1-141) (ABIN6939031)

Antigène

Voir toutes OLIG2 Anticorps
OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

Reactivité

  • 81
  • 44
  • 41
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Humain

Hôte

  • 72
  • 23
  • 1
Souris

Clonalité

  • 63
  • 33
Monoclonal

Conjugué

  • 53
  • 7
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp OLIG2 est non-conjugé

Application

  • 52
  • 40
  • 34
  • 18
  • 15
  • 13
  • 13
  • 11
  • 11
  • 9
  • 8
  • 4
  • 3
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

OLIG2-2400
  • Épitope

    • 16
    • 12
    • 9
    • 7
    • 6
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-141

    Specificité

    Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuro-epithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid / rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue (gliosis).

    Réactivité croisée (Details)

    Human,

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment of human OLIG2 protein (around aa 1-141) (exact sequence is proprietary)

    Isotype

    IgG1
  • Indications d'application

    Positive Control: THP-1 cells. Astrocytoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA and 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. Also available WITHOUT BSA & azide at 1.0mg/ml.

    Date de péremption

    24 months
  • Antigène

    OLIG2 (Oligodendrocyte Lineage Transcription Factor 2 (OLIG2))

    Autre désignation

    OLIG2

    Sujet

    Basic helix loop helix protein class B1 (bHLHB1), basic helix-loop-helix protein 19 (bHLHe19), OLIG2, Oligodendrocyte lineage transcription factor 2, Oligodendrocyte specific bHLH transcription factor 2, Oligodendrocyte transcription factor 2, Protein kinase C-binding protein 2 (PRKCBP2), RACK17,OLIG2 (Marker of Glial Brain Tumors)
    Cellular localisation: Nuclear

    Poids moléculaire

    30-40kDa

    ID gène

    10215, 176977

    UniProt

    Q13516
Vous êtes ici:
Chat with us!